CDE在2023年9月28日发布了《化学仿制药注射剂过量灌装研究技术指导原则》（征求意见稿），该征求意见稿主要参考了FDA《Allowable Excess Volume/Content in ...

US FDA has issued a guidance on Allowable Excess Volume and Labeled Vial Fill Size in injectable drug and biological products. These norms are essentially issued to clarify the Center for Drug ...

Still, excessive volume levels at live shows will never cease to be an issue. It has been since amplification was invented and likely will be until the last band plays the last show in the history ...

And, as such, the volume loss should not be a cause for concern. To describe this phenomenon, the research team coined a new phrase: "amyloid-removal-related pseudo-atrophy" or ARPA.